{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:24:54Z","timestamp":1769847894354,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tube.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T14:46:28Z","timestamp":1499179588000},"page":"62-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Immunological characterization of latent tuberculosis infection in a low endemic country"],"prefix":"10.1016","volume":"106","author":[{"given":"Roelof A.","family":"de Paus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista E.","family":"van Meijgaarden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet H.","family":"Kamphorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M.","family":"Arend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom H.M.","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone A.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"Lonnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1183\/13993003.01397-2015","article-title":"Monitoring latent tuberculosis infection diagnosis and management in The Netherlands","volume":"47","author":"Erkens","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1183\/09031936.00201609","article-title":"Tuberculosis contact investigation in low prevalence countries: a European consensus","volume":"36","author":"Erkens","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5588\/ijtld.13.0589","article-title":"Added value of interferon-gamma release assays in screening for tuberculous infection in The Netherlands","volume":"18","author":"Erkens","year":"2014","journal-title":"Int J Tuberc Lung Dis Off. J Int Union Against Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.140099","article-title":"Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches","volume":"91","author":"Goletti","year":"2014","journal-title":"J\u00a0Rheumatol. Suppl"},{"key":"10.1016\/j.tube.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"601737","DOI":"10.1155\/2013\/601737","article-title":"Interferon-Gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence","volume":"2013","author":"Trajman","year":"2013","journal-title":"Pulm Med"},{"key":"10.1016\/j.tube.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/00365540701642179","article-title":"T-SPOT.TB Test(R) results in adults with Mycobacterium avium complex pulmonary disease","volume":"40","author":"Adams","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tube.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2017.07.001_bib10","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/IAI.00457-09","article-title":"Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria","volume":"77","author":"Lin","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/eji.201141602","article-title":"Double- and monofunctional CD4(+) and CD8(+) T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals","volume":"41","author":"Commandeur","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tube.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02803-15","article-title":"Interferon gamma release assays for latent tuberculosis: what are the sources of variability?","volume":"54","author":"Banaei","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.tube.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-gamma) release Assays. A systematic review","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.tube.2017.07.001_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1155\/2012\/420392","article-title":"Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges","volume":"19","author":"Pai","year":"2012","journal-title":"Can Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/thx.2010.143180","article-title":"Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review","volume":"67","author":"Zwerling","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.tube.2017.07.001_bib18","first-page":"1286","article-title":"Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts","volume":"12","author":"Franken","year":"2008","journal-title":"Int J Tuberc Lung Dis Off. J Int Union Against Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2017.07.001_bib19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/CVI.00185-07","article-title":"Follow-up study of tuberculosis-exposed supermarket customers with negative tuberculin skin test results in association with positive gamma interferon release assay results","volume":"14","author":"Franken","year":"2007","journal-title":"Clin Vacc. Immunol CVI"},{"key":"10.1016\/j.tube.2017.07.001_bib20","first-page":"346","article-title":"Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment","volume":"66","author":"Bartalesi","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.tube.2017.07.001_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2015.00217","article-title":"Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination","volume":"6","author":"Boer","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2017.07.001_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CVI.00132-07","article-title":"Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in\u00a0vitro incubation","volume":"14","author":"Leyten","year":"2007","journal-title":"Clin Vacc. Immunol CVI"},{"key":"10.1016\/j.tube.2017.07.001_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-9-182","article-title":"New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response","volume":"9","author":"Butera","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tube.2017.07.001_bib24","doi-asserted-by":"crossref","first-page":"e18315","DOI":"10.1371\/journal.pone.0018315","article-title":"Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders","volume":"6","author":"Delogu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2017.07.001_bib25","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/JCM.43.5.2070-2074.2005","article-title":"ESAT-6\/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex\u00a0vivo enzyme-linked immunospot assay in the Gambia","volume":"43","author":"Hill","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.tube.2017.07.001_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micinf.2005.05.019","article-title":"Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients","volume":"8","author":"Abramo","year":"2006","journal-title":"Microbes Infect\/Institut Pasteur"},{"key":"10.1016\/j.tube.2017.07.001_bib27","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/13993003.01157-2016","article-title":"Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in The Netherlands","volume":"48","author":"Erkens","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib28","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"Menzies","year":"2008","journal-title":"Int J Tuberc Lung Dis Off. J Int Union Against Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2017.07.001_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/ciu795","article-title":"Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis","volume":"60","author":"Rozot","year":"2015","journal-title":"Clin Infect Dis Off. Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.tube.2017.07.001_bib30","first-page":"588","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.tube.2017.07.001_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.tube.2017.07.001_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2017.07.001_bib33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1183\/09031936.00010612","article-title":"Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection","volume":"40","author":"Mulder","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1164\/rccm.201502-0232OC","article-title":"Risk assessment of tuberculosis in contacts by IFN-gamma release assays. A tuberculosis network european trials group study","volume":"191","author":"Zellweger","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2017.07.001_bib35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1183\/13993003.01012-2016","article-title":"Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis","volume":"48","author":"Petruccioli","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2017.07.001_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ebiom.2014.12.001","article-title":"Biomarkers can identify pulmonary tuberculosis in HIV-infected drug users months prior to clinical diagnosis","volume":"2","author":"Sloot","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tube.2017.07.001_bib37","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A\u00a0blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217301166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979217301166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T08:50:20Z","timestamp":1569660620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979217301166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":37,"alternative-id":["S1472979217301166"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2017.07.001","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological characterization of latent tuberculosis infection in a low endemic country","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}